The immune regulation and therapeutic potential of the SMAD gene family in breast cancer

Zhuo Chen,Yu Wang,Xiaodi Lu,Hong Chen,Yiran Kong,Liwei Rong,Guonian Wang
DOI: https://doi.org/10.1038/s41598-024-57189-6
IF: 4.6
2024-03-23
Scientific Reports
Abstract:Breast cancer is a serious threat to human health. The transforming growth factor-β signaling pathway is an important pathway involved in the occurrence and development of cancer. The SMAD family genes are responsible for the TGF-β signaling pathway. However, the mechanism by which genes of the SMAD family are involved in breast cancer is still unclear. Therefore, it is necessary to investigate the biological roles of the SMAD family genes in breast cancer. We downloaded the gene expression data, gene mutation data, and clinical pathological data of breast cancer patients from the UCSC Xena database. We used the Wilcox test to estimate the expression of genes of the SMAD family in cancers. And the biological functions of SMAD family genes using the DAVID website. The Pearson correlation method was used to explore the immune cell infiltration and drug response of SMAD family genes. We conducted in biological experiments vitro and vivo. In this study, we integrated the multi-omics data from TCGA breast cancer patients for analysis. The expression of genes of SMAD family was significantly dysregulated in patients with breast cancer. Except for SMAD6, the expression of other SMAD family genes was positively correlated. We also found that genes of the SMAD family were significantly enriched in the TGF-β signaling pathway, Hippo signaling pathway, cell cycle, and cancer-related pathways. In addition, SMAD3, SMAD6, and SMAD7 were lowly expressed in stage II breast cancer, while SMAD4 and SMAD2 were lowly expressed in stage III cancer. Furthermore, the expression of genes of the SMAD family was significantly correlated with immune cell infiltration scores. Constructing a xenograft tumor mouse model, we found that SMAD3 knockdown significantly inhibited tumorigenesis. Finally, we analyzed the association between these genes and the IC50 value of drugs. Interestingly, patients with high expression of SMAD3 exhibited significant resistance to dasatinib and staurosporine, while high sensitivity to tamoxifen and auranofin. In addition, SMAD3 knockdown promoted the apoptosis of BT-549 cells and decreased cell activity, and BAY-1161909 and XK-469 increased drug efficacy. In conclusion, genes of the SMAD family play a crucial role in the development of breast cancer.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper aims to explore the immunoregulatory role and therapeutic potential of the SMAD gene family in breast cancer. Specifically, the study attempts to address the following key issues: 1. **Expression and Regulatory Mechanisms of the SMAD Gene Family in Breast Cancer**: - Researchers analyzed multi-omics data from breast cancer patients in the TCGA database and found that the expression of SMAD gene family members is significantly dysregulated in breast cancer tissues. - Except for SMAD6, the expression of other SMAD family genes is positively correlated. 2. **Expression Differences of the SMAD Gene Family in Different Stages of Breast Cancer**: - The study found significant differences in the expression of SMAD family genes among breast cancer patients at different TNM stages. For example, SMAD3, SMAD6, and SMAD7 are lowly expressed in stage II breast cancer, while SMAD4 is lowly expressed in stage III breast cancer. 3. **Relationship Between the SMAD Gene Family and Immune Cell Infiltration**: - The expression of SMAD family genes is significantly correlated with immune cell infiltration scores, indicating their important role in the tumor immune microenvironment. - Specifically, the expression of SMAD2, SMAD3, SMAD4, and SMAD5 is positively correlated with the infiltration of various immune cells (such as CD8 memory cells and helper T cells), while negatively correlated with other immune cells like effector CD8 cells. 4. **Association Between the SMAD Gene Family and Drug Sensitivity**: - Patients with high expression of SMAD3 exhibit significant resistance to certain anticancer drugs (such as dasatinib and staurosporine) but show high sensitivity to tamoxifen and auranofin. - Knockout of SMAD3 significantly inhibited tumorigenesis, promoted apoptosis of BT-549 cells, and reduced cell viability. In summary, through multi-omics data analysis and experimental validation, this paper reveals the important biological functions of the SMAD gene family in breast cancer and its potential therapeutic value.